Upgrade to SI Premium - Free Trial

BioNTech (BNTX) PT Raised to $450 at Canaccord Genuity

August 23, 2021 7:21 AM
Canaccord Genuity analyst Arlinda Lee raised the price target on BioNTech (NASDAQ: BNTX) to $450.00 (from $240.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles